TCM
Tygh Capital Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-16,374
| Closed | -$6.76M | – | 90 |
|
|
2021
Q3 | $6.76M | Sell |
16,374
-3,427
| -17% | -$1.41M | 0.91% | 56 |
|
|
2021
Q2 | $7.33M | Sell |
19,801
-216
| -1% | -$79.9K | 1% | 50 |
|
|
2021
Q1 | $5.8M | Sell |
20,017
-3,316
| -14% | -$961K | 0.82% | 55 |
|
|
2020
Q4 | $5.83M | Sell |
23,333
-11,577
| -33% | -$2.89M | 0.91% | 53 |
|
|
2020
Q3 | $7.91M | Sell |
34,910
-28,248
| -45% | -$6.4M | 1.5% | 24 |
|
|
2020
Q2 | $11M | Sell |
63,158
-3,953
| -6% | -$689K | 2.3% | 8 |
|
|
2020
Q1 | $8.47M | Buy |
67,111
+290
| +0.4% | +$36.6K | 1.9% | 18 |
|
|
2019
Q4 | $10.2M | Sell |
66,821
-440
| -0.7% | -$67.2K | 1.69% | 20 |
|
|
2019
Q3 | $8.9M | Buy |
67,261
+36,371
| +118% | +$4.81M | 1.58% | 24 |
|
|
2019
Q2 | $4.38M | Sell |
30,890
-11,501
| -27% | -$1.63M | 0.74% | 66 |
|
|
2019
Q1 | $6.16M | Sell |
42,391
-25,201
| -37% | -$3.66M | 1.08% | 44 |
|
|
2018
Q4 | $7.65M | Buy |
67,592
+15,532
| +30% | +$1.76M | 1.6% | 21 |
|
|
2018
Q3 | $7M | Buy |
+52,060
| New | +$7M | 1.15% | 37 |
|
|
2018
Q1 | – | Sell |
-64,356
| Closed | -$7.04M | – | 95 |
|
|
2017
Q4 | $7.04M | Buy |
64,356
+28,249
| +78% | +$3.09M | 1.33% | 20 |
|
|
2017
Q3 | $3.9M | Sell |
36,107
-14,460
| -29% | -$1.56M | 0.78% | 66 |
|
|
2017
Q2 | $5.12M | Sell |
50,567
-11,220
| -18% | -$1.13M | 1.16% | 38 |
|
|
2017
Q1 | $5.56M | Buy |
61,787
+30,885
| +100% | +$2.78M | 1.3% | 31 |
|
|
2016
Q4 | $2.35M | Buy |
+30,902
| New | +$2.35M | 0.59% | 77 |
|